Patents by Inventor Tyler Witte

Tyler Witte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240241080
    Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the bound complex to migrate toward the electrode with opposite charge of the bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the bound complex band and one or both of the migration pattern and the migration velocity.
    Type: Application
    Filed: March 27, 2024
    Publication date: July 18, 2024
    Inventors: Peter GALEN, Ariane Elizabeth ERICKSON, David Richard BELL, Matthew Christian LIND, Tyler WITTE, Umut Atakan GURKAN
  • Publication number: 20240201132
    Abstract: The disclosed methods and systems use multi-spectral imaging of band data in point-of-care devices during active electrophoresis test runs to detect sensitive disease state compounds, such as hemoglobin and its variants and sub-variants. The multi-spectral imaging identifies an imaging wavelength of light that, when emitted towards the electrophoresis strip, optimizes images of the electrophoresis strip that are captured during the test. These optimized images allow for detection of the target compound, particularly at low concentrations and with low limits of detection (LoD).
    Type: Application
    Filed: April 25, 2022
    Publication date: June 20, 2024
    Inventors: Peter GALEN, David John SAYLER, James Daren BLEDSOE, Muhammad Noman HASAN, Joshua King HOYT, Jered WIKANDER, Tyler WITTE, Alireza AVANAKI, Yiyang FEI, Anne ROCHELEAU, Umut Atakan GURKAN
  • Patent number: 11971384
    Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: April 30, 2024
    Assignee: Hemex Health, Inc.
    Inventors: Peter Galen, Ariane Elizabeth Erickson, David Richard Bell, Matthew Christian Lind, Tyler Witte, Umut Atakan Gurkan
  • Publication number: 20230400431
    Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 14, 2023
    Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte
  • Patent number: 11740203
    Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: August 29, 2023
    Assignee: Hemex Health, Inc.
    Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte
  • Patent number: 11255815
    Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: February 22, 2022
    Assignee: Hemex Health, Inc.
    Inventors: Peter Galen, Ariane Elizabeth Erickson, David Richard Bell, Matthew Christian Lind, Tyler Witte, Umut Atakan Gurkan
  • Publication number: 20220042946
    Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
    Type: Application
    Filed: October 18, 2021
    Publication date: February 10, 2022
    Inventors: Peter GALEN, Ariane Elizabeth ERICKSON, David Richard BELL, Matthew Christian LIND, Tyler WITTE, Umut Atakan GURKAN
  • Publication number: 20210341360
    Abstract: A point-of-care diagnostic system that includes a cartridge and a reader. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The sample can be processed for data collection and analysis to provide interpretative results indicative of a disorder, condition, disease and/or infection of the patient. Processing can include external sonication and conjugating non-magnetic target material with magnetic nanoparticles and non-magnetic solids.
    Type: Application
    Filed: October 17, 2019
    Publication date: November 4, 2021
    Inventors: Peter GALEN, Oren BERNSTEIN, James Daren BLEDSOE, Daniel E. GRUPP, Joshua King HOYT, David John SAYLER, James THORNE, Jered WIKANDER, Tyler WITTE
  • Publication number: 20210325341
    Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Inventors: Peter GALEN, Ariane Elizabeth ERICKSON, David Richard BELL, Matthew Christian LIND, Tyler WITTE, Umut Atakan GURKAN
  • Publication number: 20200408715
    Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.
    Type: Application
    Filed: June 25, 2020
    Publication date: December 31, 2020
    Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte